(Press-News.org) LOS ANGELES (April 15, 2021) -- Researchers have discovered a new way to transform the tissues surrounding prostate tumors to help the body's immune cells fight the cancer. The discovery, made in human and mouse cells and in laboratory mice, could lead to improvements in immunotherapy treatments for prostate cancer, the second most common cancer in men in the US.
Using a technique called epigenetic reprogramming, investigators altered the tumor and tumor microenvironment by inhibiting expression of a protein known as enhancer of zeste homolog2, or EZH2, which is found at high levels in prostate cancer. This protein helps tumors resist checkpoint inhibitor immunotherapies, which are designed to block certain other proteins that can stop immune cells from killing cancer cells.
By inhibiting EZH2, the investigators were able to reduce the tumor's resistance to checkpoint inhibitors. If confirmed in clinical trials, the research findings, recently published in the peer-reviewed journal Nature Cancer, potentially may increase the percentage of prostate cancer patients who successfully respond to this therapy.
"Our goal is to one day apply our strategy to fire up the immune system of prostate cancer patients and make the cancer vulnerable to the patient's own immune system," said molecular and cellular biologist Leigh Ellis, PhD, scientific director of the Center for Urologic Research Excellence at Cedars-Sinai Cancer and corresponding author of the multi-institutional study.
The study's findings were made through the study of cancer epigenetics. Whereas traditional genetics describe the way DNA sequences in our genes are passed from one generation to the next, epigenetics describe how genes get turned on and off in an individual's body to produce proteins. Disrupted epigenetic mechanisms can alter gene function and form cancerous cells.
The investigators zeroed in on the EZH2 mechanisms that altered the gene function of prostate cells, switching off the immune response, and on how to switch it back on.
Well-established research has demonstrated that EZH2 inactivates several tumor-suppression genes in numerous cancers, including prostate. Based on those earlier findings, the researchers genetically and chemically inhibited EZH2 to activate important immune-related genes called interferon-stimulated genes. Interferons are proteins that alert the immune system to attack cancer cells.
This action, called "viral mimicry," involves reopening dormant areas of the genome--an organism's complete set of genetic instructions--that typically are closed for action. That process prompted the tumor cell to activate the interferon-stimulated genes, which signaled the immune system to enhance the response to checkpoint inhibitor therapy.
"We discovered that viral mimicry is key to activating interferon-stimulated genes," Ellis said. "With epigenetic therapy, we're able to get the immune response we want."
In recent years, immunotherapy drugs have been added to chemotherapy regimens, or used alone, to help a patient's own immune cells attack cancer, but the response, while promising in treating skin, colon, lung, liver and other cancers, is still low--currently, about 70% to 85% of patients taking immunotherapy drugs fail to respond to them.
The researchers' study findings hold the potential for personalized treatment approaches going forward, which may include combined regimens of EZH2 inhibitors and checkpoint inhibitors as a novel strategy to increase prostate cancer response to checkpoint immunotherapy. Following recent Food and Drug Administration approval of EZH2 inhibitors, Ellis and Edwin M. Posadas, MD, the medical director of the Center for Urologic Research Excellence, and associate professor in the Division of Oncology at Cedars-Sinai Cancer, plan to launch a Cedars-Sinai-based clinical trial of an EZH2 inhibitor in prostate cancer patients.
"We are extremely pleased to see Dr. Ellis, one of our recent researcher recruits, contribute such a significant advance to the prostate cancer field," said Dan Theodorescu, MD, PhD, director of the Cedars-Sinai Cancer enterprise and professor of Surgery and Pathology and Laboratory Medicine. "Prostate cancer has been a challenge to treat even with immunotherapy, and this work will help overcome some of the barriers and hopefully improve outcome for patients."
INFORMATION:
Research reported in this study was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute; the Dana-Farber Cancer Institute Faculty Start-Up Funds; a Prostate Cancer Foundation Young Investigator Award; the Emory University Faculty Start-Up Funds and the Emory University School of Medicine Flow Cytometry Core. Epizyme Pharmaceuticals supplied EPZ0011989.
DOI: 10.1038/s43018-021-00185-w
Read more on the Cedars-Sinai blog: Prostate Cancer Active Surveillance
DNA ligase proteins, which facilitate the formation of bonds between separate strands of DNA, play critical roles in the replication and maintenance of DNA. The human genome encodes three different DNA ligase proteins, but only one of those proteins--DNA ligase III (LIG3)--is expressed in mitochondria. LIG3 is therefore crucial for mitochondrial health, and inactivation of the homologous protein in mice causes profound mitochondrial dysfunction and early embryonic mortality. In an article recently published in the peer-reviewed journal Brain, a team of European and Japanese scientists, led by Dr. Mariko Taniguchi-Ikeda from Fujita Health University Hospital, describes a set of seven patients with a novel ...
Infection with parasitic intestinal worms (helminths) can apparently cause sexually transmitted viral in-fections to be much more severe elsewhere in the body. This is shown by a study led by the Universities of Cape Town and Bonn. According to the study, helminth-infected mice developed significantly more severe symptoms after infection with a genital herpes viruses (Herpes Simplex Virus). The researchers suspect that these results can also be transferred to humans. The results have now appeared in the journal Cell Host & Microbe.
In sub-Saharan Africa, both worm infections and sexually transmitted viral diseases are extremely com-mon. These viral infections are also often particularly severe. It is possible that these findings ...
LIBREVILLE, Gabon (April 15 2021) - A team of scientists led by the Wildlife Conservation Society (WCS) and working closely with experts from the Agence Nationale des Parcs Nationaux du Gabon (ANPN) compared methodologies to count African forest elephants (Loxodonta cyclotis), which were recently acknowledged by IUCN as a separate, Critically Endangered species from African savannah elephants. The study is part of a larger initiative in partnership with Vulcan Inc. to provide the first nationwide census in Gabon for more than 30 years. The results of the census are expected later this ...
Fifty-five years ago, America's death toll from automobile crashes was sky-high. Nearly 50,000 people died every year from motor vehicle crashes, at a time when the nation's population was much smaller than today.
But with help from data generated by legions of researchers, the country's policymakers and industry made changes that brought the number killed and injured down dramatically.
Research led to changes in everything from road construction and driver's license rules, to hospital trauma care, to laws and social norms about wearing seatbelts and driving while drunk or using a cell phone.
Now, researchers at the University ...
Immune checkpoint inhibitors have transformed cancer care to the point where the popular Cox proportional-hazards model provides misleading estimates of the treatment effect, according to a new study published April 15 in JAMA Oncology.
The study, "Development and Evaluation of a Method to Correct Misinterpretation of Clinical Trial Results With Long-term Survival," suggests that some of the published survival data for these immunotherapies should be re-analyzed for potential misinterpretation.
The study's senior author, Yu Shyr, PhD, the Harold L. Moses Chair ...
Scientists at the University of Southampton have conducted a study that highlights the importance of studying a full range of organisms when measuring the impact of environmental change - from tiny bacteria, to mighty whales.
Researchers at the University's School of Ocean and Earth Science, working with colleagues at the universities of Bangor, Sydney and Johannesburg and the UK's National Oceanography Centre, undertook a survey of marine animals, protists (single cellular organisms) and bacteria along the coastline of South Africa.
Lead researcher and postgraduate student ...
The dynamics of the neural activity of a mouse brain behave in a peculiar, unexpected way that can be theoretically modeled without any fine tuning, suggests a new paper by physicists at Emory University. Physical Review Letters published the research, which adds to the evidence that theoretical physics frameworks may aid in the understanding of large-scale brain activity.
"Our theoretical model agrees with previous experimental work on the brains of mice to a few percent accuracy -- a degree which is highly unusual for living systems," says Ilya Nemenman, Emory professor of physics and biology and senior author of the paper.
The ...
Scientists at the Institute for Cooperative Upcycling of Plastics (iCOUP), an Energy Frontier Research Center led by Ames Laboratory, have discovered a chemical process that provides biodegradable, valuable chemicals, which are used as surfactants and detergents in a range of applications, from discarded plastics. The process has the potential to create more sustainable and economically favorable lifecycles for plastics.
The researchers targeted their work on the deconstruction of polyolefins, which represents more than half of all discarded plastics, and includes nearly every kind of product imaginable-- toys, food packaging, pipe systems, water ...
A new review published in EPJ H by Clara Matteuzzi, Research Director at the National Institute for Nuclear Physics (INFN) and former tenured professor at the University of Milan, and her colleagues, examines almost three decades of the LHCb experiment - from its conception to operation at the Large Hadron Collider (LHC) - documenting its achievements and future potential.
The LCHb experiment was originally conceived to understand the symmetry between matter and antimatter and where this symmetry is broken - known as charge conjugation parity (CP) violation. Whilst this may seem like quite an obscure area of study, it addresses one of the Universe's most fundamental questions: how it came to be dominated ...
As the world's energy demands grow, so too does growing concern over the environmental impact of power production. The need for a safe, clean, and reliable energy source has never been clearer. Fusion power could fulfil such a need. A review paper published in EPJ H examines the 6-decade history of neutral particle analysis (NPA), developed in Ioffe Institute, Saint Petersburg, Russia, a vital diagnostic tool used in magnetic plasma confinement devices such as tokamaks that will house the nuclear fusion process and generate the clean energy of the future.
As ...
